Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.

(R)-2-((2R,3R)-2-{(R)-2-[((R)-1-{(S)-2-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-methyl-pentanoyl}-pyrrolidine-2-carbonyl)-amino]-4-carbamoyl-butyrylamino}-3-hydroxy-butyrylamino)-propionic acid

ID: ALA157727

PubChem CID: 44371979

Max Phase: Preclinical

Molecular Formula: C34H52N7O14P

Molecular Weight: 813.80

Molecule Type: Protein

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(=O)N[C@H](C)C(=O)O)[C@@H](C)O

Standard InChI:  InChI=1S/C34H52N7O14P/c1-17(2)15-25(39-30(46)24(37-20(5)43)16-21-8-10-22(11-9-21)55-56(52,53)54)33(49)41-14-6-7-26(41)31(47)38-23(12-13-27(35)44)29(45)40-28(19(4)42)32(48)36-18(3)34(50)51/h8-11,17-19,23-26,28,42H,6-7,12-16H2,1-5H3,(H2,35,44)(H,36,48)(H,37,43)(H,38,47)(H,39,46)(H,40,45)(H,50,51)(H2,52,53,54)/t18-,19-,23-,24+,25+,26-,28-/m1/s1

Standard InChI Key:  PPBWJQKFDZLYQS-XWFHMPNSSA-N

Molfile:  

     RDKit          2D

 56 57  0  0  1  0  0  0  0  0999 V2000
    2.4667   -1.6917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7875   -1.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1667   -0.3792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7750   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5417   -0.7125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0542   -0.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1958   -0.1792    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500   -1.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0542   -1.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9250   -0.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0292   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5667   -1.7000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6875   -0.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4042   -0.3917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6458   -1.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1833   -2.3792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0417    0.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3000   -0.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0458   -3.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4167    0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4875   -0.3667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8917   -2.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6542   -0.7917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0083    0.4958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7667   -1.4167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4417   -0.3167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9417    0.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667   -2.8250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3875   -2.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7833   -1.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6542    0.2708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.1750    0.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3625   -3.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5042   -2.7667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2917   -1.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9083   -0.0042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3958   -0.8542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6667   -2.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9000   -1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8125   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2667   -2.7417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4583   -1.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0542    1.3083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9958   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5958   -0.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6708   -1.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2708   -0.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6167   -1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5500    0.6625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3875   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0667   -2.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5958   -3.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8917    0.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8042    0.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2042   -3.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7542   -2.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  5  1  6
  4  3  1  0
  5 10  1  0
  9  6  1  1
  7 21  1  0
  8  2  1  0
  9  1  1  0
 10 18  1  0
 11 12  1  0
  8 12  1  6
 13  6  1  0
 14  4  1  0
 15 11  1  0
 15 16  1  1
 17 20  1  0
 18 13  1  1
 19 16  1  0
 20 14  1  0
 21 40  1  0
 22 39  1  0
 23  2  2  0
 24  7  2  0
 25  4  2  0
 26  6  2  0
 27 10  2  0
 28 11  2  0
  8 29  1  0
 15 30  1  0
 31 17  2  0
  3 32  1  0
 33 19  2  0
 34 22  2  0
 18 35  1  0
 36  7  1  0
 37  7  1  0
 38  1  1  0
 39 35  1  0
 40 47  2  0
 41 22  1  0
 42 30  1  0
 43 17  1  0
 44 42  1  0
 45 42  2  0
 46 44  2  0
 47 45  1  0
  9 48  1  0
 32 49  1  6
 50 38  1  0
 51 29  1  0
 52 19  1  0
 20 53  1  6
 54 32  1  0
 55 51  1  0
 56 51  1  0
 48 50  1  0
 40 46  1  0
M  END

Alternative Forms

Associated Targets(Human)

STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Calculated Properties

Molecular Weight: 813.80Molecular Weight (Monoisotopic): 813.3310AlogP: -2.07#Rotatable Bonds: 21
Polar Surface Area: 333.19Molecular Species: ACIDHBA: 11HBD: 10
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.78CX Basic pKa: CX LogP: -3.01CX LogD: -9.42
Aromatic Rings: 1Heavy Atoms: 56QED Weighted: 0.06Np Likeness Score: 0.12

References

1. Ren Z, Cabell LA, Schaefer TS, McMurray JS..  (2003)  Identification of a high-affinity phosphopeptide inhibitor of Stat3.,  13  (4): [PMID:12639546] [10.1016/s0960-894x(02)01050-8]
2. Mandal, Pijus K PK and 9 more authors.  2009-04-23  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.  [PMID:19334714]
3. Mandal, Pijus K; Ren, Zhiyong; Chen, Xiaomin; Xiong, Chiyi and McMurray, John S.  2009-10-08  Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.  [PMID:19728728]
4. Ioannidis, Stephanos S and 20 more authors.  2011-01-13  Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.  [PMID:21138246]
5. Mandal, Pijus K and 10 more authors.  2011-05-26  Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.  [PMID:21486047]
6. Ren, Xiaomei X and 8 more authors.  2010-12-09  Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.  [PMID:24900231]
7. Haftchenary, Sina S and 15 more authors.  2013-11-14  Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.  [PMID:24900612]
8. LaPorte, Matthew G and 11 more authors.  2014-11-01  2-Guanidinoquinazolines as new inhibitors of the STAT3 pathway.  [PMID:25288188]
9. Miklossy, Gabriella G and 15 more authors.  2015-10-08  Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.  [PMID:26331426]
10. Löcken, Hauke H, Clamor, Cinzia C and Müller, Klaus K.  2018-07-27  Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.  [PMID:30003778]
11. Huang, Wei W and 8 more authors.  2018-09-05  Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis.  [PMID:30145375]
12. Chen, Shao-Ru SR and 7 more authors.  2018-10-01  Andrographolide derivative as STAT3 inhibitor that protects acute liver damage in mice.  [PMID:30228000]
13. Li, Chungen C and 8 more authors.  2019-01-15  A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).  [PMID:30472602]
14. Zhou, Haibin and 18 more authors.  2019-12-26  Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.  [PMID:31747516]
15. Kaoud, Tamer S and 7 more authors.  2020-01-15  NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.  [PMID:31784187]
16. Cerulli, Robert A and 6 more authors.  2020-06-15  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.  [PMID:32503696]
17. Brotherton-Pleiss, Christine and 13 more authors.  2021-01-14  Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors.  [PMID:33352047]

Source